.png){kind=small}
.png){kind=small}
BackTable / VI / Podcast / Episode #485
Mastering Microwave Ablation in HCC Treatment
with Dr. Zach Berman
Are you up-to-date on microwave ablation for hepatocellular carcinoma (HCC) treatment? Dr. Zachary Berman and host Dr. Michael Barraza discuss this treatment modality. They cover the spectrum of pre-procedure imaging and planning, procedure steps, and tips for navigating difficult cases. Dr. Berman is a hepatobiliary interventional oncologist and Associate Clinical Professor of Radiology at UC San Diego School of Medicine.
This podcast is supported by an educational grant from:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2024, October 4). Ep. 485 – Mastering Microwave Ablation in HCC Treatment [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. Zach Berman
Dr. Zachary Berman is an interventional radiologist at the University of California San Diego in San Diego, California.
Dr. Michael Barraza
Dr. Michael Barraza is a practicing interventional radiologist (and all around great guy) with Radiology Associates in Baton Rouge, LA.
Synopsis
Dr. Berman highlights the importance of a multidisciplinary approach, referral pathways, and the role of tumor boards in decision-making. The doctors also cover various ablation technologies, pre-procedure embolization, hydrodissection, biopsy considerations, and the incorporation of immunotherapy in ongoing research. Finally, Dr. Berman emphasizes the importance of ultrasound skills and presents some cases.
Timestamps
00:00 - Introduction
10:09 - Techniques and Technologies
17:26 - Planning and Performing Ablations
21:35 - Tumor Size and Margins
25:09 - Navigational Software and Skills
30:47 - Hydrodissection Techniques
33:20 - Post-Ablation Imaging and Follow-Up
35:52 - Future of Ablation in IR and Cases
Resources
Liver Imaging Reporting & Data System (LI-RADS®):
https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS
Liver Cancer Stages (BCLC):
https://www.cancer.gov/types/liver/what-is-liver-cancer/stages
Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795153/
Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698169/
Prospective double-blinded randomized controlled trial of Microwave versus RadioFrequency Ablation for hepatocellular carcinoma (McRFA trial):
https://www.hpbonline.org/article/S1365-182X(20)30023-X/fulltext#:~:text=A%20total%20of%2093%20patients,RFA%20in%20treating%20small%20HCC.
Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial:
https://jgo.amegroups.org/article/view/26929/html#:~:text=to%2080%20years.-,There%20were%20no%20statistically%20significant%20differences%20between%20both%20groups%20regarding,HCC%20ablation%20(Table%202).
Surgical microwave ablation for the treatment of hepatocellular carcinoma in 791 operations:
https://www.sciencedirect.com/science/article/abs/pii/S1365182X23020002
Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): An international, multicenter, phase III randomized controlled trial:
https://meetings.asco.org/abstracts-presentations/234189
One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach:
https://pubmed.ncbi.nlm.nih.gov/23732261/
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
